Mirae Asset Global Investments’s Inhibrx, Inc. Common Stock INBX Stock Holding History

Mirae Asset Global Investments’s Portfolio INBX Stock Details INBX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-21,920	Closed	-$537K	–	2693
2024 Q1	$537K	Buy	21,920 +1,426	+7%	+$52K	﹤0.01%	1864
2023 Q4	$779K	Buy	20,494 +1,331	+7%	+$28.5K	﹤0.01%	1746
2023 Q3	$352K	Sell	19,163 -755	-4%	-$15.8K	﹤0.01%	2063
2023 Q2	$516K	Sell	19,918 -1,438	-7%	-$33.6K	﹤0.01%	1934
2023 Q1	$403K	Buy	21,356 +6,729	+46%	+$156K	﹤0.01%	2030
2022 Q4	$360K	Buy	14,627 +2,079	+17%	+$61.1K	﹤0.01%	2056
2022 Q3	$226K	Buy	+12,548	New	+$226K	﹤0.01%	2295

Other funds holding INBX

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Mirae Asset Global Investments's INBX Position: Q2 2024 in Review

Mirae Asset Global Investments sold out of Inhibrx, Inc. Common Stock (INBX) in Q2 2024, closing a stake of 21,920 shares — an estimated $537K sold.

Mirae Asset Global Investments first reported a position in INBX in Q3 2022 and held it in 7 quarters. The position peaked at $779K in Q4 2023. 2 funds tracked by Wall St. Rank hold INBX as of Q2 2024.

Mirae Asset Global Investments reported no remaining Inhibrx, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Mirae Asset Global Investments sold 21,920 Inhibrx, Inc. Common Stock shares in Q2 2024, an estimated $537K.
Mirae Asset Global Investments first reported a position in Inhibrx, Inc. Common Stock in Q3 2022 and held it in 7 quarters.
Mirae Asset Global Investments's Inhibrx, Inc. Common Stock position peaked at $779K in Q4 2023.
2 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q2 2024.

Based on Mirae Asset Global Investments's 13F filing for Q2 2024, filed 30 Jul 2024.